The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.
about
Hepatitis E virus and coliphages in waters proximal to swine concentrated animal feeding operationsHepatitis E virus infection in the liver transplant recipients: Clinical presentation and managementInfections after orthotopic liver transplantationHepatitis E and blood donation safety in selected European countries: a shift to screening?Enhancement of interferon induction by ORF3 product of hepatitis E virus.Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States.Molecular detection of hepatitis E virus in sheep from southern Xinjiang, China.Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi.Maternal-Fetal Hepatitis E Transmission: Is It Underestimated?High pressure processing and its application to the challenge of virus-contaminated foods.Hepatitis E- Is it a risk to transfusion safety?Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.Host immune status and response to hepatitis E virus infection.Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infectionEpizootiological study of rodent-borne hepatitis E virus HEV-C1 in small mammals in Hanoi, Vietnam.Risk factors for hepatitis E virus infection and disease.Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015.The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.Is cholesterol a mediator of cold-induced cancer?Hepatitis E Virus (HEV) Detection and Quantification by a Real-Time Reverse Transcription-PCR Assay Calibrated to the World Health Organization Standard for HEV RNA.The role of hepatitis E virus infection in adult Americans with acute liver failure.A cross-sectional study of hepatitis E virus infection in healthy people directly exposed and unexposed to pigs in a rural community in northern Thailand.Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.Transmission of hepatitis E virus by transfusion: what is the risk?Public health risks associated with hepatitis E virus (HEV) as a food‐borne pathogenKnowledge gaps and research priorities in the prevention and control of hepatitis E virus infection.Colder environments are associated with a greater cancer incidence in the female population of the United States.Hepatitis E infection in a patient with transfusion-dependent β thalassemia.Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?
P2860
Q23914664-B8C95BBD-4ACE-4971-95D1-4CEB6E067D4EQ26775005-1C0ADA61-184C-4E1D-B84C-276C4C999FF3Q27023182-0AED4D5D-133D-4A60-AB10-578C13C23F2CQ33601663-FF102AC9-A167-4F09-8AED-005BEB51AEB9Q34057885-553B1C71-E427-4D01-95E4-B41C9443926AQ35597008-6E29C78F-9AAB-4C08-B279-8459982F5D51Q35654527-2EAE220B-63F6-4E0B-879B-614A432CA11EQ35780244-C4793418-C49B-441C-927B-5EDF575EB8DDQ35905989-33577DE5-F591-4DEA-A255-B1EEB92C9881Q36662829-75B91E07-409A-4BCB-8123-B6EA91CA1610Q36732650-125A77C4-B089-42D7-A797-F74F4E941CE5Q36973372-E8ACA4C1-015F-45FE-BBD8-9B020F43384FQ37544940-C4196484-B6F3-4E3D-9D38-D757D878A879Q37573028-73B45FC7-9E53-4D59-B5A5-1BB41CA2B1A9Q37621333-EB7A2E6C-84CA-4E7D-B91C-009FC51A34EBQ38268414-4B4FFBD0-3851-4033-8D5C-5F6E78CA4BE2Q38538122-F78B5D4F-B4B4-4C7E-A7BD-4494F8BFC988Q38691510-58B685DD-5728-42F2-BD9D-924A9C5A61A9Q38962794-F26C9306-C34E-4C67-9E48-0BFC705AB449Q40075493-7F79A6FA-7917-404C-A937-0BC863D4FC20Q40321569-DF5483DB-465A-400F-97C1-0ECA0E315E56Q40663054-653B3166-8E89-4C66-90BF-8477DCEA0919Q44702918-5BE86A4A-F273-4ACF-B36C-62F2FE53199BQ45324099-A9C67406-7953-41DB-A77C-FCBC030BAE27Q45348271-566A761D-21AA-4703-AF0B-B688F8C2E670Q47159881-0BBBD8F6-33ED-4B04-8D1D-9840CCC23F0DQ47556196-63DD0579-E377-4277-992E-EDFDEE5E3902Q47612846-407B7228-B7B4-4943-9FDA-B793E6D0A299Q51792006-746818D9-282B-47A8-B118-28DC63FBD982Q56000615-7172DD59-2B0D-426E-BB64-0FF920EB0F51
P2860
The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The epidemiology of hepatitis ...... ng immunocompromised patients.
@en
The epidemiology of hepatitis ...... ng immunocompromised patients.
@nl
type
label
The epidemiology of hepatitis ...... ng immunocompromised patients.
@en
The epidemiology of hepatitis ...... ng immunocompromised patients.
@nl
prefLabel
The epidemiology of hepatitis ...... ng immunocompromised patients.
@en
The epidemiology of hepatitis ...... ng immunocompromised patients.
@nl
P2860
P356
P1476
The epidemiology of hepatitis ...... ong immunocompromised patients
@en
P2093
Kenrad E Nelson
P2860
P304
P356
10.1586/ERI.11.138
P577
2011-12-01T00:00:00Z